Hiper

Hiper Biotech is a specialized medical technology company focused on the development and manufacturing of advanced in vitro diagnostic (IVD) solutions. The company primarily utilizes chemiluminescence immunoassay (CLIA) and point-of-care testing (POCT) platforms to provide rapid and accurate diagnostic results across various clinical settings. Their product portfolio includes automated analyzers and a wide range of reagent kits targeting infectious diseases, cardiac markers, inflammatory indicators, and metabolic disorders. By integrating research, production, and sales, Hiper Biotech aims to enhance clinical decision-making through high-performance diagnostic tools. The company serves both domestic and international markets, positioning itself as a key player in the evolving landscape of decentralized medical testing.